Avalyn Pharma Inc. (AVLN)Healthcare | Biotechnology | Boston, United States | NasdaqGS
28.78 USD
+0.39
(1.374%)
⇧
(May 29, 2026, 4 p.m.
EDT)
After hours: 28.78 |
Hot Take ↕ | May 25, 2026, 4:14 a.m. EDT
The immediate outlook is neutral due to a lack of statistical data to confirm short-term momentum, though recent price action shows volatility without a clear trend. However, the long-term investment case is severely compromised by deteriorating fundamentals; the company reports negative earnings, negative free cash flow, and a negative book value, indicating significant financial distress. Furthermore, the multi-year price trajectory reveals a structural decline with consecutive negative annual returns, confirming that the market has consistently reassessed the business quality downward over time. Finally, there is no dividend income available, as the company has not issued any payouts in the last five years. |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 1,275,300,736 |
| Forward P/E | -15.15 |
| Website | https://www.avalynpharma.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.037300766 |
| Address1 | 105 W First Street |
| All Time High | 32.23 |
| All Time Low | 25.05 |
| Ask | 29.5 |
| Ask Size | 3 |
| Average Analyst Rating | 1.3 - Strong Buy |
| Average Daily Volume10 Day | 265,830 |
| Average Daily Volume3 Month | 673,590 |
| Average Volume | 673,590 |
| Average Volume10Days | 265,830 |
| Bid | 28.29 |
| Bid Size | 1 |
| Book Value | -10.107 |
| City | Boston |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 28.78 |
| Current Ratio | 10.188 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,778,803,200 |
| Day High | 29.7999 |
| Day Low | 26.88 |
| Display Name | Avalyn Pharma |
| Ebitda | -91,250,000 |
| Ebitda Margins | 0.0 |
| Eps Current Year | -1.94 |
| Eps Forward | -1.9 |
| Eps Trailing Twelve Months | -2.04 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 28.5245 |
| Fifty Day Average Change | 0.2555008 |
| Fifty Day Average Change Percent | 0.00895724 |
| Fifty Two Week Change Percent | -3.7300766 |
| Fifty Two Week High | 32.23 |
| Fifty Two Week High Change | -3.4499989 |
| Fifty Two Week High Change Percent | -0.107043095 |
| Fifty Two Week Low | 25.05 |
| Fifty Two Week Low Change | 3.7300014 |
| Fifty Two Week Low Change Percent | 0.14890225 |
| Fifty Two Week Range | 25.05 - 32.23 |
| First Trade Date Milliseconds | 1,777,555,800,000 |
| Float Shares | 14,454,887 |
| Forward Eps | -1.9 |
| Forward P E | -15.147369 |
| Free Cashflow | -50,577,500 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 50 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.0 |
| Held Percent Institutions | 0.52919996 |
| Implied Shares Outstanding | 44,312,047 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,026-04-30 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Avalyn Pharma Inc. operates as a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases. The company provides inhaled formulations of oral medicines directly to the lungs. Its current pipeline is focused on treating pulmonary fibrosis. Its products include AP01 and AP02, inhaled formulations of pirfenidone and nintedanib for the treatment of progressive pulmonary fibrosis and idiopathic pulmonary fibrosis; and AP03, a fixed-dose combination of inhaled pirfenidone and nintedanib to deliver dual antifibrotic mechanisms. Avalyn Pharma Inc. was formerly known as Genoa Pharmaceuticals, Inc. and changed its name to Avalyn Pharma Inc. in July 2017. The company was incorporated in 2011 and is based in Boston, Massachusetts. |
| Long Name | Avalyn Pharma Inc. |
| Market | us_market |
| Market Cap | 1,275,300,736 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_224094665 |
| Net Income To Common | -85,204,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,258,019,014 |
| Number Of Analyst Opinions | 4 |
| Open | 28.41 |
| Operating Cashflow | -81,484,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | (206) 707-0340 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 28.78 |
| Post Market Time | 1,780,085,405 |
| Previous Close | 28.39 |
| Price Eps Current Year | -14.835052 |
| Price Hint | 2 |
| Price To Book | -2.8475313 |
| Profit Margins | 0.0 |
| Quick Ratio | 9.861 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.25 |
| Region | US |
| Regular Market Change | 0.390001 |
| Regular Market Change Percent | 1.37373 |
| Regular Market Day High | 29.7999 |
| Regular Market Day Low | 26.88 |
| Regular Market Day Range | 26.88 - 29.7999 |
| Regular Market Open | 28.41 |
| Regular Market Previous Close | 28.39 |
| Regular Market Price | 28.78 |
| Regular Market Time | 1,780,084,800 |
| Regular Market Volume | 268,091 |
| Return On Assets | -0.41739 |
| Return On Equity | -0.68344 |
| Sand P52 Week Change | 0.2794361 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 44,312,047 |
| Shares Percent Shares Out | 0.0127 |
| Shares Short | 0 |
| Short Name | Avalyn Pharma Inc. |
| Short Percent Of Float | 0.0127 |
| Short Ratio | 0.6 |
| Source Interval | 15 |
| State | MA |
| Symbol | AVLN |
| Target High Price | 80.0 |
| Target Low Price | 51.0 |
| Target Mean Price | 59.0 |
| Target Median Price | 52.5 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -2.04 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 28.5245 |
| Two Hundred Day Average Change | 0.2555008 |
| Two Hundred Day Average Change Percent | 0.00895724 |
| Type Disp | Equity |
| Volume | 268,091 |
| Website | https://www.avalynpharma.com |
| Zip | 2,127 |